Literature DB >> 15062195

Sepsis and cholestasis.

Richard H Moseley1.   

Abstract

Sepsis-associated cholestasis should always be considered as part of the differential diagnosis of jaundice in the hospitalized or critically ill patient. The development of a disproportionate elevation of serum bilirubin in comparison with serum alkaline phosphatase and serum aminotransferases should be considered an early warning sign of an underlying infection, even in the absence of fever,leukocytosis, or other signs or symptoms. Prompt recognition and appropriate medical and surgical intervention may reduce morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15062195     DOI: 10.1016/S1089-3261(03)00134-X

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  18 in total

1.  Scoring system for traumatic liver injury (SSTLI) in polytraumatic patients: a predictor of mortality.

Authors:  H H Kim; J H Kim; C-Y Park; H M Cho
Journal:  Eur J Trauma Emerg Surg       Date:  2014-10-21       Impact factor: 3.693

2.  Impaired cell functions of hepatocytes incubated with plasma of septic patients.

Authors:  Martin Sauer; Cristof Haubner; Thomas Mencke; Gabriele Nöldge-Schomburg; Steffen Mitzner; Jens Altrichter; Jan Stange
Journal:  Inflamm Res       Date:  2012-02-28       Impact factor: 4.575

3.  Liver impairment in critical illness and sepsis: the dawn of new biomarkers?

Authors:  Martin Kluge; Frank Tacke
Journal:  Ann Transl Med       Date:  2019-12

Review 4.  The role of inflammation in cholestasis: clinical and basic aspects.

Authors:  Astrid Kosters; Saul J Karpen
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

5.  Human adrenomedullin and its binding protein ameliorate sepsis-induced organ injury and mortality in jaundiced rats.

Authors:  Juntao Yang; Rongqian Wu; Mian Zhou; Ping Wang
Journal:  Peptides       Date:  2010-02-02       Impact factor: 3.750

Review 6.  [Abnormal liver function tests in the intensive care unit].

Authors:  A Koch; K Streetz; J Tischendorf; C Trautwein; F Tacke
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-10       Impact factor: 0.840

Review 7.  Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes.

Authors:  Françoise Van Bambeke; Paul M Tulkens
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 8.  Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.

Authors:  Jaap Mulder; Saul J Karpen; Uwe J F Tietge; Folkert Kuipers
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

Review 9.  Clinical review: The liver in sepsis.

Authors:  Nicolas Nesseler; Yoann Launey; Caroline Aninat; Fabrice Morel; Yannick Mallédant; Philippe Seguin
Journal:  Crit Care       Date:  2012-10-30       Impact factor: 9.097

10.  Variant etiologies of neonatal cholestasis and their outcome: a Middle East single-center experience.

Authors:  Mohamed Abdel-Salam El-Guindi; Magdy Anwar Saber; Samar Ahmed Shoeir; Ayat Roushdy Abdallah; Ahmad Mohamed Sira
Journal:  Clin Exp Hepatol       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.